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Comparison of three reference methods for
the measurement of intracellular pH using
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and Geoffrey S. Payne
31P magnetic resonance spectroscopy (31P MRS) can measure intracellular pH (pHi) using the chemical shift difference
between pH-dependent inorganic phosphate (Pi) and a pH-independent reference peak. This study compared three
different frequency reference peaks [phosphocreatine (PCr), α resonance of adenosine triphosphate (αATP) and water
(using 1H MRS)] in a cohort of 10 volunteers and eight patients with non-Hodgkin’s lymphoma (NHL). Well-resolved
chemical shift imaging (CSI) spectra were acquired on a 1.5T scanner for muscle, liver and tumour. The pH was calcu-
lated for all volunteers and patients using the available methods. The consistency of the resulting pH was evaluated.
The direct Pi–PCr method was best for those spectra with a very well-deﬁned PCr, such as muscle (pH=7.05 ± 0.02). In
liver, the Pi–αATP method gave more consistent results (pH=7.30 ± 0.06) than the calibrated water-based method
(pH=7.27 ± 0.11). In NHL nodes, themeasured pH using the Pi–αATPmethod was 7.25 ± 0.12. Given that themeasured
range includes some biological variation in individual patients, treatment-related changes of the order of 0.1 pH
units should be detectable. © 2013 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.
Keywords: 31P MRS; intracellular pH; non-Hodgkin’s lymphoma; reference peak; accuracy measurement; java-based
magnetic resonance user interface (jMRUI)
INTRODUCTION
Most tumours, contrary to expectation, exhibit slightly alkaline
values of intracellular pH (pHi) (1), which have been associated
with a favourable environment for tumour growth (2). Inhibition
of tumour growth may occur with anticancer agents that acidify
the intracellular tumour environment, such as inhibitors of the
monocarboxylate transporter (3) that blocks the membrane
transport of the ﬁnal products of glycolysis. In these instances,
the measurement of drug-induced pHi changes offers the oppor-
tunity to verify the mechanism of drug action.
Measurement of pHi using
31P MRS was ﬁrst proposed about 30
years ago (4). The initial human applications includedmuscle exercise
studies (5,6) and the detection of some muscle pathologies, such as
the glycogen storage disease McArdle’s syndrome (7). The measure-
ment of pH by 31P MRS (4,8) relies on the chemical shift difference
between pH-dependent inorganic phosphate (Pi) and a pH-indepen-
dent reference peak. In vivo 31P MRS has the advantage of being a
noninvasive and nonperturbing technique, enabling longitudinal
clinical studies to be performed through a course of treatment.
Three internal frequency references have been suggested tomea-
sure pHi: two
31P-derived peaks and a 1H-derived peak. The phos-
phocreatine (PCr) peak is widely used for pH measurement in
muscle (9–11) as a result of its strong nonoverlapping single reso-
nance, but, in other tissues, as well as in tumours, it may be less suit-
able owing to its low concentration. One alternative is to use the α
resonance of adenosine triphosphate (αATP) (12,13), as this com-
pound is visible in most spectra and is relatively insensitive to pH
and ion content (4). A third method is based on the 1H MRS signal
from tissue water acquired from the same region (14), whose reso-
nance frequency is scaled to create a ‘virtual reference’ peak in the
31P spectrum. Although this method requires a dual-receiver coil,
the water resonance is a well-deﬁned single peak with a very good
signal-to-noise ratio. In addition, technology has improved since the
initial evaluation of the method, permitting simpliﬁcation of the
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measurement protocol, particularly with regard to digital resolution
of the frequency synthesiser, while modern shielded gradients
substantially reduce the ﬁeld shift from eddy currents.
These methods have all been available for some time. However,
given the recent interest in exploring the use of pHi as a biomarker
of some new targeted anticancer therapies, it is timely to compare
the three methods on modern hardware, and to obtain estimates
of their precision. In this study, we calibrated the water reference
method in human calf (gastrocnemius) muscle, compared with
PCr, αATP and thewater reference inmuscle and liver (in volunteers),
and applied the best method to obtain a measurement of pH in a
pilot cohort of patients with non-Hodgkin’s lymphoma (NHL).
Several other 31P MRSmethods of measuring pH based on chem-
ical shifts among the ATP peaks (15) or between βATP and PCr peaks
(16) are available. In addition to pH value measurement, some of
these methods can simultaneously estimate intracellular [Mg2+]
concentration. Such complex equations, however, require further
calibrations to determine unknown constants for each study design.
In the present study, we focused on comparing themost established
pH-dependent peak (Pi) with three options for the reference peak.
EXPERIMENTAL
Volunteers and patients
Data were obtained from 10 healthy volunteers, aged 24–58
years (ﬁve right gastrocnemius muscle and ﬁve liver spectra),
and eight newly diagnosed patients with NHL, aged 38–79 years
(three abdomen, three chest, one neck and one knee spectra).
The NHL subtypes were; four diffuse large B-cell lymphomas,
two follicular lymphomas and two mixed lymphomas (diffuse
large B-cell lymphoma + follicular lymphoma). All volunteers
and patients gave written informed consent and the scanning
protocol was approved by the local ethical committee. Only patients
with superﬁcial and/or bulky tumour mass (>2 × 2 × 2 cm3 on prior
computed tomography scan) were included in the study.
MR examination
All data were acquired using a 1.5 T Avanto scanner (Siemens,
Erlangen, Germany) using three custom-built dual 1H/31P surface
coils (17–19) of 5, 8 and 12 cm in diameter. In the volunteer
measurements, the 8 cm coil was chosen for the superﬁcial calf mus-
cle examination, whereas the 12 cm coil offered better coverage of
the whole liver. For each patient, the appropriate surface coil was
chosen individually, based on tumour size and location. Attention
was paid to position the acquisition voxel within viable tumour tis-
sue, excluding large blood vessels, necrotic or cystic regions.
The MR protocol consisted of: a) three orthogonal anatomical
images for planning the spectral acquisition; b) 1H single voxel
spectroscopy; and c) 3D 1H-decoupled 31P chemical shift imag-
ing (CSI). The anatomical images were based on a T2 steady-state
gradient echo sequence with the following parameters: ﬁeld of
view, 400 mm; TR/TE = 3.79/1.9 ms; 12 slices with a thickness
of 7 mm. A water spectrum was acquired using a 1H MRS point-
resolved spectroscopy sequence (withTR/TE=2000/135ms; vector size,
1024; bandwidth, 1000 Hz; 60 averages; total acquisition time,
~2 min). The transmit frequency of the 1H MRS acquisition was
centred to the water frequency following the standard
procedure of the scanner software. The 31P CSI protocol
(TR = 1000 ms; RF pulse calibrated to 45° at the voxel centre;
vector size, 1024; 8 × 8 × 8 phase-encoding steps; two
averages; spectral width, 2000 Hz; full k-space coverage with
100% Hamming ﬁlter; total acquisition time, ~17 min) acquired
information from the same voxel as for the water spectrum.
The Hamming ﬁlter was applied in scanner software to smooth
the truncation effect caused by the limited coverage of k space
(eight steps). The 31P transmit frequency was set in two steps.
Firstly, the frequency was calibrated using a 31P reference
sample (triphenyl phosphate) sited within the 31P coil housing.
Secondly, the scanner frequency was offset from this reference
frequency by a known value (–3563 Hz) to centre the spectrum
relative to the metabolites (centre frequency between γATP and
αATP). All volunteer spectra (muscle or liver) were derived from a
27 mL isotropic voxel. The patient voxel size varied from 15.6 to
125 mL depending on the tumour volume. The same shimming
was used for both 1H and 31P acquisitions. No water spectra were
acquired in the patient cohort.
To test for frequency shifts from eddy current effects, localised
and unlocalised phantom data were acquired for both 1H and
31P MRS using the 5 cm 1H/31P coil. Two spherical phantoms
of 3 cm in diameter were used. The 1H phantom contained a
0.13 mM MnCl2 water solution, and the
31P phantom contained
0.1 M NaH2PO4 doped with 0.24 mM NiCl2. Both phantoms
were positioned slightly off-isocentre (~10 cm laterally) similar
to most in vivo locations. As phantom data were expected to
have a good signal-to-noise ratio and not to suffer from any
motion, the number of averages used for in vivo acquisitions
could be reduced. The phantom data were hence acquired with
10 averages for the 1H single-voxel spectroscopy and one
average for 31P CSI.
Post-processing and pH measurement
Spectra were processed using the JAVA-based magnetic resonance
user interface (jMRUI) v.5 software and quantiﬁed using a nonlinear
least-squares algorithm [AMARES (20)]. pH values were calculated
using three reference peak methods for the volunteer data and
two for the patient data. The pH calculation used the following
calibrated form of the Henderson–Hasselbalch equation (11,13):
pH ¼ 6:75þ log10 δ – 3:27ð Þ= 5:69 – δð Þ½ 
where δ is the chemical shift frequency difference between
pH-dependent Pi and a pH-independent reference peak, mea-
sured in parts per million (ppm).
Method 1 (PCr based) used the chemical shift difference δ
between Pi and PCr:
δ ¼ f Pi  f PCr
Method 2 (αATP based) used the same equation, but with δ
calculated from the chemical shift of αATP:
δ ¼ f Pi  f αATP  7:56
where 7.56 ppm represents the expected frequency of the
centre of the αATP doublet peak relative to PCr.
Method 3 [water-derived PCr reference, a simpliﬁed method of
Madden et al. (14)] used the water signal from the 1H spectrum,
acquired from the same voxel as for 31P MRS, to estimate the
frequency of the PCr peak in the 31P spectrum (see Fig. 1):
f PCr ¼ fH2O  k
This method relies on the fact that the absolute frequency
positions (in Hz) of both water and PCr are proportional to the
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local magnetic ﬁeld Blocal, which is the main magnetic ﬁeld B0
affected by any local susceptibility effects. The absolute fre-
quency of PCr is then deﬁned as:
f PCr ¼
γ31P  Blocal  1 σPCrð Þ
2π
where γ31P is the
31P gyromagnetic ratio and σPCr is the chemical
shielding effect for PCr. The absolute frequency of water is simi-
larly deﬁned and, by dividing the two equations, we obtain:
f PCr
fH2O
¼
γ31P  Blocal  1σPCrð Þ
2π
γ1H  Blocal  1σH2Oð Þ
2π
¼ γ31P  1 σPCrð Þ
γ1H  1 σH2Oð Þ
¼ k ¼ constant:
Thus, once one has measured or calculated k, one can use the
previous relation to estimate the PCr frequency from the water
frequency. In the previous work of Madden et al. (14), it was
necessary to include corrections for limited frequency resolution
of the synthesiser, and for frequency shifts caused by eddy
currents. These should not be required with modern hardware,
but localised pulse-acquire spectra were acquired in a test
object to check that there was no frequency shift from eddy
current effects.
The multiplication factor k was calibrated experimentally in
in vivo muscle datasets exhibiting high PCr, and then applied
in liver spectra. The same equation as for Method 1 was subse-
quently applied.
RESULTS AND DISCUSSION
1H phantom and 31P phantom data were acquired in both
localised and unlocalised spectra. The 1H MRS measured a water
peak at the same frequency (0 Hz) for both types of acquisition.
Similarly, a 31P signal was acquired at the same position (131.83 Hz)
for localised versus unlocalised spectra. The sampling interval
was 1 Hz for all 1H and 31P experiments. These results sug-
gest that, if present, effects from eddy currents were smaller
than 1 Hz. Therefore, no eddy current corrections were
applied to further acquisitions.
Well-resolved spectra were acquired from healthy volunteers
and patients with NHL despite the relatively deep position of
some voxels (depth range, 4–8 cm from the coil). Figure 2
illustrates example ﬁtted spectra for each type of data acquisi-
tion. Small, but measurable, PCr peaks were observed in liver
and tumour spectra. The lack of motion gating, however, meant
that contamination from intense PCr signals of superﬁcial muscle
may have contributed to these peaks.
In muscle, the average value of the constant k between
the 31P MRS frequency of PCr and the 1H MRS frequency
of water was 0.404804239 ± 0.000000015. The mean mea-
sured position of the water reference in the 31P spectra
was 0.0004 ± 0.0367 ppm.
pH values in the three tissues using the different methods are
shown in Table 1. pH measurements in muscle were the most
consistent, probably owing to the well-deﬁned PCr peak and
absence of tissue motion, with Method 1 (Pi–PCr) exhibiting a
minimal standard deviation (SD) (0.02 pH units). In liver, the
Figure 1. Example of 1H and 31P MR spectra acquired at 1.5 T in a
healthy volunteer muscle used to calibrate the water-based method.
H2O, water; PCr, phosphocreatine; Pi, inorganic phosphate; α, β, γ, nucle-
oside triphosphates. Peaks of interest of each spectrum are labelled in
green. For this particular example, the measured frequencies were fH2O
= 63.641294 MHz and fPCr = 25.762264 MHz, giving k = 0.40480421.
The frequency of water signal from the 1H spectrum was multiplied by
the experimentally derived constant k to create a virtual peak in the
31P spectrum, called the estimated PCr. Subsequently, pH was calculated
using the Henderson–Hasselbalch equation and the chemical shift
difference between the measured Pi and the estimated PCr.
Figure 2. Example 31P MR spectra acquired at 1.5 T for muscle, liver
and non-Hodgkin’s lymphoma (NHL). PCr, phosphocreatine; PDE,
phosphodiesters; Pi, inorganic phosphate; PME, phosphomonoesters;
α, β, γ, nucleoside triphosphates. Peaks of interest are labelled in green.
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PCr peak was less clearly detected and may have arisen from
muscle outside the selected voxel; the αATP and water reference
methods were most consistent, with the Pi–αATP method
giving the smallest variation of 0.06 pH units.
This study analysed data from volunteers and patients in a
sequential manner. Observations derived from the analysis of
volunteer data generated slight modiﬁcation of the acquisition
protocol for the patient cohort. All three methods of measure-
ment of pH presented here were tested on volunteers (muscle
and liver tissue), but only two were further applied to tumours
in patients. The water-derived method failed to demonstrate
improvement in accuracy of measurement for both muscle and
liver data. Therefore, in order to avoid extra acquisition with no
expected beneﬁt, no water acquisition was performed for the
patient cohort.
In tumour (NHL), the Pi–αATP method yielded a slightly
alkaline pH of 7.25 with a much smaller SD (0.12) than using
the PCr method (0.17). Among the three types of tissue
investigated here, the greatest variation in the measurement
of pH was in tumours, but, even here, the variation was rela-
tively low (0.12 pH units). Given the biological variation of
tumours, these results are encouraging and should result in
a good intra-patient repeatability.
The performance of the water reference method in liver was
disappointing, given the good signal-to-noise ratio and well-
deﬁned single resonance of the water peak. Although the use of
two separate measurements tends to increase uncertainty, the
consistent result in muscle (SD = 0.04 ppm) shows that intrinsically
the method is working well. Factors such as digital resolution,
ampliﬁer frequency linearity between 31P and 1H, and arithmetic
precision of the analysis were the same for muscle and liver
measurements. However, in liver, the slightly larger water
linewidths (12.6 Hz in liver, compared with 10.7 Hz in muscle)
and the presence of motion may have affected the result.
The conclusion of this study used direct comparison of the SD
values for each method and tissue. A statistical analysis of vari-
ance, such as F-test (two pH methods) and Bartlett test (three
pH methods), was performed. The results may be regarded with
caution because of the small sample size (ﬁve and eight data
points). The reported p values (at a signiﬁcance level of 95%)
were 0.31 (muscle), 0.5 (liver) and 0.35 (tumour). These statistical
tests show no signiﬁcant difference between the measured SD
values of the different methods. However, although the statisti-
cal analysis does not support a preferred method, two further
considerations inﬂuence a recommendation. The water method
(with its extended acquisition time) showed no beneﬁt for the
quality of pH measurement. The PCr–Pi method could result in
the PCr peak visible in liver/tumour spectra being contaminated
from adjacent muscle tissue, making this method less reliable.
For these reasons, we recommend the use of the αATP method
for liver and tumour acquisitions.
It is generally acknowledged that the Pi peak has both intra-
and extracellular components. In this study, only one single Pi
peak of the MR spectrum was resolved, implying that the mea-
sured pH was a weighted average of intracellular and extracellu-
lar pH. However, the contributions from pHi are expected to be
at least 85% of the total pH (1). Such a contribution of the
intracellular volume to the measured pH can be estimated when
the total tumour volume and the fractional volume of extracellu-
lar water are known (21). Calculations show that, if the
extracellular volume does not exceed 55%, then pH measured
by 31P MRS largely represents pHi (22). This extracellular com-
partment is expected to be larger in tumour tissue than in
normal tissue owing to necrotic or cystic regions. The extracellu-
lar contamination was minimised here by careful positioning of
the voxel of interest to avoid such regions.
Overall repeatability, will be inﬂuenced by a combination of fac-
tors, e.g. voxel repositioning uncertainty, coil sensitivity, shimming
quality, subject motion and random noise. To detect drug response
in the context of measurement variability, repeatability acquisitions
are desirable in any longitudinal trial. The noninvasive nature of the
examination and the lack of need for an extrinsic contrast agent
make this easier to implement. The 31P MRS method (including
images and calibrations), however, requires a total scanning time
of about 40 min per visit and its application is limited to superﬁcial
tumours of about 2–3 cm in size, or to larger tumours if deeper, for
signal detection using a surface coil.
In conclusion, pH was successfully calculated for all volunteers
and patients. The direct Pi–PCr method is best only for spectra with
very well-deﬁned PCr, such as muscle. The Pi–αATP method mea-
sured pH in liver with an SD value of 0.06 units, and in tumours
with an SD value of 0.12 pH units, and is preferred in these tissues.
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Table 1. Intracellular pH measurements (mean ± SD) in healthy volunteers and patients with non-Hodgkin’s lymphoma (NHL)
using three different methods
PCr based αATP based Water based
pH measurement Mean SD Mean SD Mean SD
Volunteer: muscle 7.05 0.02 7.00 0.03 7.03 0.04
Volunteer: liver 7.21 0.12 7.30 0.06 7.27 0.11
Patient: NHL 7.17 0.17 7.25 0.12 na na
na, not applicable.
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